Download
41606_2024_Article_107.pdf 1,77MB
WeightNameValue
1000 Titel
  • Non-invasive hemodynamic monitoring during initiation of positive airway pressure treatment in patients with obstructive sleep apnea: a feasibility study
1000 Autor/in
  1. Müller, Christoph |
  2. Kerl, Jens |
  3. Dellweg, Dominic |
1000 Verlag
  • BioMed Central
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-08-26
1000 Erschienen in
1000 Quellenangabe
  • 8(1):13
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s41606-024-00107-6 |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:sec> <jats:title>Background</jats:title> <jats:p>The association of obstructive sleep apnea (OSA) with cardiovascular morbidity has been repeatedly reported in numerous studies and argues for treatment initiation even in the absence of significant day time sleepiness. While the long-term consequences of positive airway pressure (PAP) treatment on OSA related comorbidities like secondary hypertension are based on substantial clinical evidence, less is known about the immediate hemodynamic effects.</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>This study tried to investigate the impact of PAP treatment on different hemodynamic parameters in 48 patients with OSA by extending the standard polysomnographic assessment with non-invasive hemodynamic monitoring using impedance cardiography (ICG). On two consecutive nights under diagnostic and therapeutic conditions, polysomnographic and hemodynamic data were acquired. In addition, we subdivided the participants according to their treatment related change in stroke volume (SV) and assigned the hemodynamic measurements to the corresponding sleep stage.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>Comparing both conditions, a non-statistically significant decrease in SV and cardiac output (CO) was observed for all participants. Treatment initiation was associated with a statistically significant prolongation of the pre-ejection period (PEP) for the entire study population (<jats:italic>p</jats:italic> = 0.001) and the subgroup with decreasing SV (<jats:italic>p</jats:italic> = 0.008). In addition, systolic blood pressure (SBP) (<jats:italic>p</jats:italic> = 0.026) and pulse pressure (PP) (<jats:italic>p</jats:italic> = 0.041) were lowered significantly for patients with a therapeutically reduced SV under treatment conditions. A higher BMI (<jats:italic>p</jats:italic> = 0.020) and a more pronounced reduction of the respiratory distress index (RDI) (<jats:italic>p</jats:italic> = 0.030) and the arousal-index (<jats:italic>p</jats:italic> = 0.021) were observed for patients with decreasing SV. Correlational analysis revealed a negative relationship between the diagnostic values for both SBP (<jats:italic>r</jats:italic>=-0.324, <jats:italic>p</jats:italic> = 0.025) and PP (<jats:italic>r</jats:italic>=-0.407, <jats:italic>p</jats:italic> = 0.004) with the change in SV and a positive correlation with the change of the SBP (<jats:italic>r</jats:italic> = 0.317, <jats:italic>p</jats:italic> = 0.028) for all participants.</jats:p> </jats:sec><jats:sec> <jats:title>Conclusions</jats:title> <jats:p>To conclude, our results indicate that treatment with a PAP device in patients with OSA can lead to a decrease in SV which is associated with a lowering of the SBP. This may be caused by a reduced sympathetic tone due to less respiratory events and an improved sleep profile.</jats:p> </jats:sec>
1000 Sacherschließung
lokal Hemodynamic monitoring
lokal Impedance cardiography
lokal Research
lokal Positive airway pressure
lokal Obstructive sleep apnea
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/TcO8bGxlciwgQ2hyaXN0b3Bo|https://frl.publisso.de/adhoc/uri/S2VybCwgSmVucw==|https://frl.publisso.de/adhoc/uri/RGVsbHdlZywgRG9taW5pYw==
1000 Hinweis
  • DeepGreen-ID: 508a4d50628941cdbf9c01e5142c605e ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Philipps-Universität Marburg |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Philipps-Universität Marburg |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6524684.rdf
1000 Erstellt am 2025-07-07T06:04:06.961+0200
1000 Erstellt von 322
1000 beschreibt frl:6524684
1000 Zuletzt bearbeitet 2025-07-30T13:07:55.181+0200
1000 Objekt bearb. Wed Jul 30 13:07:55 CEST 2025
1000 Vgl. frl:6524684
1000 Oai Id
  1. oai:frl.publisso.de:frl:6524684 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source